Kolexia
Garnier Nathalie Pédiatrie
Garnier Nathalie
Pédiatrie
Institut d'hématologie et d’oncologie pédiatrique de Lyon
Lyon, France
65 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Drépanocytose Maladie de Hodgkin Thalassémie Anémie Lymphome à grandes cellules anaplasiques Cytopenia Infections à virus Epstein-Barr Bêta-Thalassémie

Collaborateurs

Voir plus
Bertrand Yves
Bertrand Yves
Institut d'hématologie et d’oncologie pédiatrique de Lyon, Lyon, France
Gauthier Vasserot Alexandra
Gauthier Vasserot Alexandra
Cabinet libéral, Charly, France
Renard Cecile
Renard Cecile
Institut d'hématologie et d’oncologie pédiatrique de Lyon, Lyon, France
Leblanc Thierry
Leblanc Thierry
Hôpital Robert-Debré, Paris, France

Industries

Voir plus
Servier
3 collaboration(s)
Dernière en 2021
SERB
1 collaboration(s)
Dernière en 2023
Sanofi
1 collaboration(s)
Dernière en 2023
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients.
British journal of haematology   03 mars 2024
AcSé CRIZOTINIB : Secured Access to Crizotinib for Patients With Tumors Harboring a Genomic Alteration on One of the Biological Targets of the Drug.
Essai Clinique (Unicancer)   26 février 2024
Pubertal development of transfusion-dependent thalassemia patients in the era of oral chelation with deferasirox: results from the French registry.
Haematologica   22 février 2024
Antinuclear antibodies associated auto-immune cytopenia in childhood is a risk factor for systemic lupus erythematosus.
Blood   16 janvier 2024
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial.
European journal of cancer (Oxford, England : 1990)   17 juillet 2023
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study: ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
Essai Clinique (Addmedica)   14 juin 2023
Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma.
Bulletin du cancer   14 avril 2023
Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia.
American journal of hematology   21 mars 2023
Alarming Upward Trend in Multidrug-Resistant Bacteria in a Large Cohort of Immunocompromised Children: A Four-Year Comparative Study.
Cancers   02 février 2023
Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study.
Haematologica   01 septembre 2022